FMI thanks Chairwoman Cantwell and Sen. Grassley for championing the PBM Transparency Act.
Today, three PBMs control 80 percent of the market.
I have long had concerns with the FTC's vague statutory authority, but at this moment, we cannot ignore the current stat...
Our investigation found that the PBM scheme encourages drug makers to spike the drug's list price in order to offer a gr...
I worked at the FTC, and I can tell you that with the Agency's overreach and activism, which will no doubt be difficult ...
It requires the FTC to study pharmaceutical intermediaries and issue a report and recommendations to Congress within one...
PBMs are blocking a cheaper product.
the rise of global e-commerce presents profound new challenges for the responsibility of governments to collect revenue ...
I believe, like Senator Cruz just said, that the consumer ought to be the point of everything that we are trying to acco...
Our bill has guardrails. It does not give FTC any new power or regulatory authority.
Any true attempt at understanding the factors driving costs must include a look at the broader supply chain.
fentanyl--which is coming from China and destroying our communities.
I hope this committee will have the same success voting this bill out.
The Cantwell-Grassley PBM Transparency Act directs the FTC to end well-known and documented PBM practices that drive up ...
The Cantwell-Grassley PBM transparency bill directs the FTC to end well-known and documented PBM practices that drive up...
